Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Astra Zeneca | Stoccolma | Salute | Prodotti farmaceutici | 2,47 Bln SEK | 37x | 8,69 | 1.596 SEK | -0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -0,2% Ribasso | Fai l’upgrade a Pro+ | |
Swedish Orphan Biovitrum | Stoccolma | Salute | Prodotti farmaceutici | 101,73 Mrd SEK | 46,6x | -1,26 | 296 SEK | -0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 11,3% Rialzo | Fai l’upgrade a Pro+ | |
Getinge | Stoccolma | Salute | Attrezzature e forniture medicali | 57,50 Mrd SEK | 22,2x | 1,14 | 211,20 SEK | 1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 10,5% Rialzo | Fai l’upgrade a Pro+ | |
Sectra | Stoccolma | Salute | Attrezzature e forniture medicali | 54,60 Mrd SEK | 122,1x | 7,22 | 283,80 SEK | 1,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -15% Ribasso | Fai l’upgrade a Pro+ | |
Camurus AB | Stoccolma | Salute | Prodotti farmaceutici | 38,58 Mrd SEK | 165,8x | -3,76 | 655 SEK | 0,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 17% Rialzo | Fai l’upgrade a Pro+ | |
Vitrolife | Stoccolma | Salute | Attrezzature e forniture medicali | 32,39 Mrd SEK | -8,5x | 0,01 | 238,60 SEK | 1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 16% Rialzo | Fai l’upgrade a Pro+ | |
Medicover | Stoccolma | Salute | Fornitori e servizi sanitari | 27,60 Mrd SEK | 105,3x | 0,33 | 183,80 SEK | 0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 17,6% Rialzo | Fai l’upgrade a Pro+ | |
Elekta | Stoccolma | Salute | Attrezzature e forniture medicali | 27,01 Mrd SEK | 23,8x | 18,11 | 70,55 SEK | 0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 3,8% Rialzo | Fai l’upgrade a Pro+ | |
Vimian Group AB | Stoccolma | Salute | Prodotti farmaceutici | 23,48 Mrd SEK | 179,8x | 1,3 | 45,20 SEK | 0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 10,1% Rialzo | Fai l’upgrade a Pro+ | |
Bonesupport | Stoccolma | Salute | Prodotti farmaceutici | 21,92 Mrd SEK | 75,3x | 0,07 | 333,60 SEK | 4,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 6,5% Rialzo | Fai l’upgrade a Pro+ | |
AddLife | Stoccolma | Salute | Ricerca medica e biotecnologica | 19,82 Mrd SEK | 168,3x | -2,35 | 162,20 SEK | 1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 5,4% Rialzo | Fai l’upgrade a Pro+ | |
Xvivo Perfusion AB | Stoccolma | Salute | Attrezzature e forniture medicali | 15,81 Mrd SEK | 127,7x | 0,39 | 504 SEK | 2,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 14,1% Rialzo | Fai l’upgrade a Pro+ | |
Biotage | Stoccolma | Salute | Attrezzature e forniture medicali | 14,66 Mrd SEK | 58,4x | -26,82 | 183 SEK | 2,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 11,2% Rialzo | Fai l’upgrade a Pro+ | |
BioArctic | Stoccolma | Salute | Ricerca medica e biotecnologica | 14,47 Mrd SEK | -163,8x | 1,19 | 164 SEK | 1,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Implantica AG | Stoccolma | Salute | Attrezzature e forniture medicali | 12 Mrd SEK | -53,2x | 2,35 | 42,60 SEK | 0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 32,9% Rialzo | Fai l’upgrade a Pro+ | |
Arjo | Stoccolma | Salute | Attrezzature e forniture medicali | 11,47 Mrd SEK | 22,4x | 0,8 | 42,12 SEK | 0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 23,8% Rialzo | Fai l’upgrade a Pro+ | |
Calliditas Therapeutics | Stoccolma | Salute | Prodotti farmaceutici | 11,24 Mrd SEK | -23,2x | 0,36 | 208 SEK | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 5,3% Rialzo | Fai l’upgrade a Pro+ | |
Biogaia | Stoccolma | Salute | Prodotti farmaceutici | 10,84 Mrd SEK | 27,1x | -8,37 | 107 SEK | -0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 38,1% Rialzo | Fai l’upgrade a Pro+ | |
Ambea | Stoccolma | Salute | Fornitori e servizi sanitari | 7,46 Mrd SEK | 14,3x | 0,2 | 88 SEK | 1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 26,4% Rialzo | Fai l’upgrade a Pro+ | |
Attendo International publ AB | Stoccolma | Salute | Fornitori e servizi sanitari | 7,33 Mrd SEK | 19,1x | 0,1 | 47,30 SEK | 0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 31,5% Rialzo | Fai l’upgrade a Pro+ | |
Cellavision | Stoccolma | Salute | Attrezzature e forniture medicali | 6,93 Mrd SEK | 47,8x | 0,97 | 288,50 SEK | -1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | -16,3% Ribasso | Fai l’upgrade a Pro+ | |
Swedencare | Stoccolma | Salute | Prodotti farmaceutici | 6,48 Mrd SEK | 85,2x | 2,06 | 40,80 SEK | 1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Surgical Science Sweden | Stoccolma | Salute | Attrezzature e forniture medicali | 6,03 Mrd SEK | 30,5x | -1,98 | 118,20 SEK | 0,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Raysearch Laboratories | Stoccolma | Salute | Attrezzature e forniture medicali | 5,35 Mrd SEK | 35,4x | 0,19 | 156,60 SEK | 0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 28,5% Rialzo | Fai l’upgrade a Pro+ | |
Flerie AB | Stoccolma | Salute | Prodotti farmaceutici | 3,30 Mrd SEK | -399x | 42,13 SEK | 0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Medistim ASA | Stoccolma | Salute | Attrezzature e forniture medicali | 2,99 Mrd SEK | 29,7x | -3,04 | 165,08 SEK | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Probi | Stoccolma | Salute | Prodotti farmaceutici | 2,97 Mrd SEK | 217,5x | -7,06 | 270 SEK | -0,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Bioinvent | Stoccolma | Salute | Ricerca medica e biotecnologica | 2,89 Mrd SEK | -7,6x | 0,31 | 43,90 SEK | 3,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
BICO Group | Stoccolma | Salute | Attrezzature e forniture medicali | 2,84 Mrd SEK | -1,9x | 0,25 | 40,40 SEK | -0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Hansa Biopharma | Stoccolma | Salute | Ricerca medica e biotecnologica | 2,80 Mrd SEK | -2,9x | -0,52 | 41,60 SEK | 1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |